| Primary |
| Drug Use For Unknown Indication |
23.8% |
| Bipolar Disorder |
17.2% |
| Product Used For Unknown Indication |
16.3% |
| Convulsion |
9.1% |
| Epilepsy |
5.5% |
| Depression |
3.9% |
| Affective Disorder |
3.1% |
| Migraine |
3.1% |
| Anxiety |
2.7% |
| Hypertension |
2.6% |
| Hypothyroidism |
1.7% |
| Bipolar I Disorder |
1.6% |
| Vitamin Supplementation |
1.5% |
| Insomnia |
1.4% |
| Mania |
1.3% |
| Drug Exposure During Pregnancy |
1.3% |
| Attention Deficit/hyperactivity Disorder |
1.1% |
| Blood Cholesterol Increased |
1.1% |
| Hypersensitivity |
1.0% |
| Pain |
1.0% |
|
| Medication Residue |
16.6% |
| Weight Increased |
11.7% |
| Alopecia |
8.0% |
| Tremor |
7.5% |
| Drug Level Decreased |
5.4% |
| Convulsion |
5.2% |
| Somnolence |
4.8% |
| Vomiting |
4.5% |
| Product Substitution Issue |
4.2% |
| Ammonia Increased |
3.7% |
| Nausea |
3.7% |
| Pancreatitis |
3.2% |
| Thrombocytopenia |
3.1% |
| Unevaluable Event |
3.1% |
| White Blood Cell Count Decreased |
3.0% |
| Drug Ineffective |
2.8% |
| Weight Decreased |
2.7% |
| Rash |
2.5% |
| Platelet Count Decreased |
2.4% |
| Hyperammonaemia |
1.8% |
|
| Secondary |
| Bipolar Disorder |
19.3% |
| Drug Use For Unknown Indication |
16.9% |
| Product Used For Unknown Indication |
12.3% |
| Convulsion |
8.8% |
| Depression |
5.5% |
| Epilepsy |
5.4% |
| Anxiety |
3.9% |
| Affective Disorder |
3.8% |
| Migraine |
2.8% |
| Schizoaffective Disorder |
2.5% |
| Pain |
2.3% |
| Hypertension |
2.3% |
| Attention Deficit/hyperactivity Disorder |
2.3% |
| Neuralgia |
2.3% |
| Insomnia |
1.9% |
| Hypothyroidism |
1.9% |
| Schizophrenia |
1.7% |
| Blood Cholesterol Increased |
1.4% |
| Gastrooesophageal Reflux Disease |
1.3% |
| Vitamin Supplementation |
1.3% |
|
| Weight Increased |
22.4% |
| Tremor |
9.3% |
| Drug Level Decreased |
6.3% |
| Somnolence |
5.7% |
| Vomiting |
5.7% |
| Alopecia |
5.5% |
| Convulsion |
5.2% |
| Medication Residue |
4.6% |
| Unevaluable Event |
4.1% |
| Weight Decreased |
4.1% |
| Drug Ineffective |
3.6% |
| Nausea |
3.3% |
| Suicide Attempt |
3.3% |
| White Blood Cell Count Decreased |
3.0% |
| Migraine |
2.7% |
| Pancreatitis |
2.5% |
| Wrong Technique In Drug Usage Process |
2.5% |
| Drug Level Increased |
2.2% |
| Thinking Abnormal |
2.2% |
| Hepatic Enzyme Increased |
1.9% |
|
| Concomitant |
| Bipolar Disorder |
16.9% |
| Depression |
9.4% |
| Convulsion |
8.9% |
| Anxiety |
8.7% |
| Product Used For Unknown Indication |
8.4% |
| Sleep Disorder |
6.6% |
| Drug Use For Unknown Indication |
6.0% |
| Schizophrenia |
5.5% |
| Pain |
4.2% |
| Psychotic Disorder |
2.8% |
| Schizoaffective Disorder |
2.7% |
| Hypertension |
2.7% |
| Affective Disorder |
2.5% |
| Agitation |
2.3% |
| Asthma |
2.2% |
| Mood Swings |
2.2% |
| Insomnia |
2.2% |
| Attention Deficit/hyperactivity Disorder |
2.1% |
| Bipolar I Disorder |
1.9% |
| Hypothyroidism |
1.7% |
|
| Type 2 Diabetes Mellitus |
24.9% |
| Granulocytopenia |
12.9% |
| Weight Increased |
9.8% |
| Leukopenia |
6.1% |
| Tremor |
5.2% |
| Vomiting |
5.0% |
| Death |
4.1% |
| Blood Triglycerides Increased |
3.4% |
| Vision Blurred |
3.2% |
| Tardive Dyskinesia |
2.9% |
| Urinary Tract Infection |
2.9% |
| Weight Decreased |
2.7% |
| Pancreatitis |
2.5% |
| Convulsion |
2.3% |
| Rash |
2.3% |
| White Blood Cell Count Decreased |
2.3% |
| Overdose |
2.0% |
| Somnolence |
2.0% |
| Pain |
1.8% |
| Drug Dose Omission |
1.6% |
|
| Interacting |
| Bipolar Disorder |
20.0% |
| Dyspepsia |
20.0% |
| Hypersensitivity |
20.0% |
| Migraine |
20.0% |
| Vitamin Supplementation |
20.0% |
|
| Visual Acuity Reduced |
66.7% |
| Treatment Noncompliance |
33.3% |
|
